Message from CEO and COO
In 2011, we brought together the medical device businesses of FosunPharma and Chindex International in a strategic partnership through the establishment of a new joint venture company - Chindex Medical Limited (CML).
FosunPharma is a leading pharmaceutical enterprise, expanding into all sectors of the healthcare industry in China and globally. Engaged primarily in the R&D, manufacturing and distribution of medicines as its core business, FosunPharma has developed substantial scale and established its market leadership in the diagnostic medicines and medical instruments markets. In China, it is the market leader in the hepatic disease, diabetes, tuberculosis and clinical diagnosis market segments. In addition, FosunPharma is expanding its activities in healthcare services and health insurance industries in global markets. Chindex International was the first foreign-invested healthcare company in China with broad operations in both the healthcare services and medical products fields. With a strong management platform, more than 30 years of experience, an unwavering reputation for excellence and an unparalleled base of brand recognition in the China healthcare services and products market, Chindex has long been recognized as a pioneer in the expansion of top quality healthcare in China.
Since inception, CML has operated and expanded the medical equipment business of Fosun Pharma with what was previously the medical distribution business of Chindex International. With the combined market strength, we are expanding the range of products and services in China and global markets.
In 2013, CML combined with a consortium of FosunPharma led investors to complete the acquisition of Alma Lasers, the global leader in aesthetic medical devices based in Israel.
The business strategy of CML will continue growth through product development in China and global acquisition.
|© 2010-2012. All rights reserved by Chindex Medical Limited|